|  Help  |  About  |  Contact Us

Publication : Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer.

First Author  McGrail DJ Year  2020
Journal  Cancer Cell Volume  37
Issue  3 Pages  371-386.e12
PubMed ID  32109374 Mgi Jnum  J:349198
Mgi Id  MGI:6400619 Doi  10.1016/j.ccell.2020.01.011
Citation  McGrail DJ, et al. (2020) Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer. Cancer Cell 37(3):371-386.e12
abstractText  Deficient DNA mismatch repair (dMMR) induces a hypermutator phenotype that can lead to tumorigenesis; however, the functional impact of the high mutation burden resulting from this phenotype remains poorly explored. Here, we demonstrate that dMMR-induced destabilizing mutations lead to proteome instability in dMMR tumors, resulting in an abundance of misfolded protein aggregates. To compensate, dMMR cells utilize a Nedd8-mediated degradation pathway to facilitate clearance of misfolded proteins. Blockade of this Nedd8 clearance pathway with MLN4924 causes accumulation of misfolded protein aggregates, ultimately inducing immunogenic cell death in dMMR cancer cells. To leverage this immunogenic cell death, we combined MLN4924 treatment with PD1 inhibition and found the combination was synergistic, significantly improving efficacy over either treatment alone.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

15 Bio Entities

Trail: Publication

0 Expression